| Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations VM Ferreira, J Schulz-Menger, G Holmvang, CM Kramer, I Carbone, ... Journal of the American College of Cardiology 72 (24), 3158-3176, 2018 | 2117 | 2018 |
| ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography: a report of the American college of cardiology foundation appropriate … Cardiac Computed Tomography Writing Group, AJ Taylor, M Cerqueira, ... Circulation 122 (21), e525-e555, 2010 | 1361 | 2010 |
| Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on … J Schulz-Menger, DA Bluemke, J Bremerich, SD Flamm, MA Fogel, ... Journal of Cardiovascular Magnetic Resonance 15 (1), 35, 2013 | 1312 | 2013 |
| Accf/acr/scct/scmr/asnc/nasci/scai/sir 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: A report of the american college of … RC Hendel, MR Patel, CM Kramer, M Poon, RC Hendel, JC Carr, ... Journal of the American College of Cardiology 48 (7), 1475-1497, 2006 | 1312 | 2006 |
| ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert … WG Hundley, DA Bluemke, JP Finn, SD Flamm, MA Fogel, MG Friedrich, ... Journal of the American College of Cardiology 55 (23), 2614-2662, 2010 | 1282 | 2010 |
| Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ... The Lancet 396 (10253), 759-769, 2020 | 1271 | 2020 |
| Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update CM Kramer, J Barkhausen, C Bucciarelli-Ducci, SD Flamm, RJ Kim, ... Journal of Cardiovascular Magnetic Resonance 22 (1), 17, 2020 | 1238 | 2020 |
| Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association MA Hlatky, P Greenland, DK Arnett, CM Ballantyne, MH Criqui, ... Circulation 119 (17), 2408-2416, 2009 | 1193 | 2009 |
| Standardized image interpretation and post-processing in cardiovascular magnetic resonance-2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees … J Schulz-Menger, DA Bluemke, J Bremerich, SD Flamm, MA Fogel, ... Journal of cardiovascular magnetic resonance 22 (1), 19, 2020 | 1006 | 2020 |
| Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols CM Kramer, J Barkhausen, SD Flamm, RJ Kim, E Nagel Journal of Cardiovascular Magnetic Resonance 10 (1), 35, 2008 | 675 | 2008 |
| ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of … MJ Wolk, SR Bailey, JU Doherty, PS Douglas, RC Hendel, CM Kramer, ... Journal of the American College of Cardiology 63 (4), 380-406, 2014 | 636 | 2014 |
| The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial MV Rocco, RS Lockridge Jr, GJ Beck, PW Eggers, JJ Gassman, T Greene, ... Kidney international 80 (10), 1080-1091, 2011 | 623 | 2011 |
| Tirzepatide for heart failure with preserved ejection fraction and obesity M Packer, MR Zile, CM Kramer, SJ Baum, SE Litwin, V Menon, J Ge, ... New England Journal of Medicine 392 (5), 427-437, 2025 | 619 | 2025 |
| Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy JJ Green, JS Berger, CM Kramer, M Salerno JACC: Cardiovascular Imaging 5 (4), 370-377, 2012 | 551 | 2012 |
| Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy. AA Young, CM Kramer, VA Ferrari, L Axel, N Reichek Circulation 90 (2), 854-867, 1994 | 511 | 1994 |
| Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis S Kuruvilla, N Adenaw, AB Katwal, MJ Lipinski, CM Kramer, M Salerno Circulation: Cardiovascular Imaging 7 (2), 250-258, 2014 | 484 | 2014 |
| The MOGE (S) classification for a phenotype–genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation E Arbustini, N Narula, GW Dec, KS Reddy, B Greenberg, S Kushwaha, ... Journal of the American College of Cardiology 62 (22), 2046-2072, 2013 | 423 | 2013 |
| Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel B Ibanez, AH Aletras, AE Arai, H Arheden, J Bax, C Berry, ... Journal of the American College of Cardiology 74 (2), 238-256, 2019 | 389 | 2019 |
| Coronary microvascular dysfunction, microvascular angina, and treatment strategies MA Marinescu, AI Löffler, M Ouellette, L Smith, CM Kramer, JM Bourque JACC: Cardiovascular imaging 8 (2), 210-220, 2015 | 372 | 2015 |
| Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy AR Patel, CM Kramer JACC: Cardiovascular Imaging 10 (10 Part A), 1180-1193, 2017 | 358 | 2017 |
Michael SalernoUCSFVerified email at ucsf.edu
